Clinical Trial Update: Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 1/Phase 2 study for metastatic prostate cancer that is resistant to hormone therapy and chemotherapy; the trial has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Prostate
• Prostate Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-10-31